Sale!

RETATRUTIDE (RT5 RT10 RT15 RT20 RT30 RT40 RT50 RT60)

RETATRUTIDE (RT5 RT10 RT15 RT20 RT30 RT40 RT50 RT60) - Image 2

RETATRUTIDE (RT5 RT10 RT15 RT20 RT30 RT40 RT50 RT60)

Name: RETATRUTIDE (RT5 RT10 RT15 RT20 RT30 RT40 RT50 RT60)
SKU: 29452
Availability: InStock

Retatrutide is a next-generation triple hormone receptor agonist engineered to activate GLP-1, GIP, and glucagon receptors simultaneously. This unique multi-pathway mechanism allows Retatrutide to work on appetite regulation, fat metabolism, and glucose control at the same time, delivering a powerful, synergistic metabolic effect.

By influencing multiple hormonal signals involved in energy balance, Retatrutide supports significant fat loss, enhanced insulin sensitivity, and improved metabolic efficiency. Emerging research suggests that triple agonists like Retatrutide may outperform traditional single or dual receptor therapies in weight management, blood sugar regulation, and overall metabolic health, making it one of the most advanced compounds currently being studied in this space.

For research use only, not a medicine.

Make Enquiry

Description
Reviews (0)

A 30mg Retatrutide formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation.
‍
Produced for laboratory research only. Not for human or veterinary consumption.

‍Each Retatrutide 30mg Research kit includes:
‍Pre-filled Research pen (30mg Retatrutide)
Research information sheet
‍
Storage:
Store refrigerated (2–8°C). Do not freeze.
Supplied in fixed-volume sealed format for laboratory analysis.